Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
Context | Citation |
---|---|
Decreases Streptococcus mutans UA159-FR - : Diferuloylmethane {Curcumin} |
👶
Effect of Addition of Curcumin Nanoparticles on Antimicrobial Property and Shear Bond Strength of Orthodontic Composite to Bovine Enamel. Journal of dentistry (Tehran, Iran) (J Dent (Tehran) ) Vol: 13 Issue 5 Pages: 373-382 Pub: 2016 Sep Epub: Authors Sodagar A , Bahador A , Pourhajibagher M , Ahmadi B , Baghaeian P , Html Article |
Decreases Streptococcus mutans UA159-FR - : Diferuloylmethane {Curcumin} |
👶
Gelucire-Based Nanoparticles for Curcumin Targeting to Oral Mucosa: Preparation, Characterization, and Antimicrobial Activity Assessment. Journal of pharmaceutical sciences (J Pharm Sci ) Vol: 104 Issue 11 Pages: 3913-3924 Pub: 2015 Nov Epub: 2015 Jul 22 Authors Hazzah HA , Farid RM , Nasra MMA , Hazzah WA , El-Massik MA , Abdallah OY , Publication |
Decreases Streptococcus mutans UA159-FR - : Diferuloylmethane {Curcumin} |
👶
Antimicrobial Activity of Monoketone Curcuminoids Against Cariogenic Bacteria. Chemistry & biodiversity (Chem Biodivers ) Vol: 15 Issue 8 Pages: e1800216 Pub: 2018 Aug Epub: 2018 Jul 15 Authors Vieira TM , Dos Santos IA , Silva TS , Martins CHG , Crotti AEM , Publication |
0 π | π’ 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]